Weight-loss therapy set to push pharma growth
India’s obesity drug market is booming, poised for significant growth driven by rising lifestyle diseases and upcoming affordable generics. Experts anticipate wider access to GLP-1 medicines, accelerating innovation through AI, and a shift towards complex generics. This transformative phase promises improved patient outcomes and positions India as a key player in global healthcare advancements.🕒 1 min read
India’s obesity drug market is booming, poised for significant growth driven by rising lifestyle diseases and upcoming affordable generics. Experts anticipate wider access to GLP-1 medicines, accelerating innovation through AI, and a shift towards complex generics. This transformative phase promises improved patient outcomes and positions India as a key player in global healthcare advancements.
Continue Reading
- Yes Bank rating upgrade: Moody’s lifts Yes Bank to Ba2 on stronger buffers, cites lower NPAs, better provisioning
- Foreign investments flood Asia: $25.7 billion flows to Taiwan, South Korea; Thailand snaps 9-month losing streak
- How To Watch FIFA World Cup 2026 Matches Absolutely Free
- Ashes: Leaked tapes, tax woes — The shocking fall of England’s WC-winning captain
- Dozens Hurt In Fuel Station Blast Heard Across Rome
- PM Modi To Host Private Dinner For Russian President Putin
- Who Was Vijay Sheoran, 30-Year-Old Indian Student Stabbed In England
- 2 Academicians Go Missing In Balochistan, Search Efforts Underway
-
India’s Newest Spin Bowling Star Gets Match Haul Of Seven Including First Five-For In County Cricket
- Deutschlands Online Casino mit Echtgeldspiel – Legales Glücksspiel für Erwachsene in Deutschland anbieten